Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6390-6395, November 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kornguth, S. E.
Right arrow Articles by Turski, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kornguth, S. E.
Right arrow Articles by Turski, P.

Preferential Binding of Radiolabeled Poly-L-lysines to C6 and U87 MG Glioblastomas Compared with Endothelial Cells in Vitro1

Steven E. Kornguth2, Tom Kalinke, H. Ian Robins, Justin D. Cohen3 and Patrick Turski

Departments of Neurology [S. E. K., T. K., H. I. R.], Physiological Chemistry [S. E. K.], Medicine [H. I. R., J. C.], Human Oncology [H. I. R., J. C.], and Radiology [P. T.], University of Wisconsin Medical Center, Madison, Wisconsin

This report describes the preparation of polylysine-diethylene triamine pentaacetic acid (DTPA)-metal ion complexes and of iodinated polylysine derivatives and the preferential binding of these polymers to glioblastomas in culture. Synthetic polylysines (DP88 and DP299) were modified covalently either with the chelator DTPA or with 125I-Bolton Hunter reagent. The polylysine (DP88) was modified initially with fluorescein to permit fluorescence cytological studies and quantitative measurements of polylysine concentrations. The polylysines contained an average of one DTPA per 16 lysyl moieties. The polylysine-DTPA derivatives were then modified with a mixture of 153Gd and stable Gd. A copolymer (DP120) of lysine and tyrosine (4:1) was modified with 125I using chloramine T as catalyst. C6 (rat) and U87 MG (human) glioblastoma cells, in culture, bound six to seven times more polylysine-DTPA-Gd than endothelial cells from either aorta or brain. Each of the tumor cell types bound 108 molecules of the modified polylysine per cell when 2.5 x 105 cells were reacted with 50 µg or greater of the polylysine-DTPA-nuclide complex. The higher molecular weight polylysines delivered more radionuclide to the cells in culture. Although the tumor cells bound more [125I]polylysine and [125I]poly(lysine HBr,tyrosine) than they bound polylysyl-DTPA-Gd, the endothelial cells and the plastic culture dish also bound more of the iodinated polymers. The stoichiometry of polylysine bound per cell suggests that the sialic acid moieties on the cell surface are the primary binding sites for polylysine derivatives. Fluorescence microscopy studies revealed that the fluorescein polylysine (DP88) and the fluorescein polylysine-DTPA nuclide complex bound the tumor cells primarily at branch points along the neuritic processes, at the edge of the perikaryon and at the terminal regions of the outgrowth processes. The polylysyl-DTPA-Gd can be used, with magnetic resonance imaging, to provide measurable contrast of the margin between C6 glioblastomas and normal brain in vivo in Wistar Furth rats.

1 Supported by a grant from the American Cancer Society, RD-298 to S. E. K., and by grants from the Graduate School of the University of Wisconsin-Madison, the Departments of Neurology and Radiology, and the Thornton Fund for Neurooncology Research, University of Wisconsin, Madison, Wisconsin.

2 To whom requests for reprints should be addressed, at Waisman Center, Room 659, University of Wisconsin, Madison, WI 53706.

3 Supported by NIH Physician Scientist Training Grant T32 CA09614.

Received 2/ 8/89. Revised 5/ 1/89. Revised 8/ 7/89. Accepted 8/18/89.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
N. S. Soukos, L. A. Ximenez-Fyvie, M. R. Hamblin, S. S. Socransky, and T. Hasan
Targeted Antimicrobial Photochemotherapy
Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2595 - 2601.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.